Director/PDMR Shareholding

RNS Number : 8743S
GlaxoSmithKline PLC
13 July 2020
 

GlaxoSmithKline plc   (the ' Company ')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D Redfern

b)

Position/status

Chief Strategy Officer

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Descriptionofthe financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

b)

Nature ofthe transaction

Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 9 July 2020, on Ordinary Shares held within an ISA. 

 

c)

Price(s)and volume(s)

Price(s)

Volume(s)

£15.9271

25

 

 

 

d)

Aggregated information

 

Aggregated volume Price

N/A (single transaction)

 

 

 

 

e)

Date ofthe transaction

2020-07-10

f)

Placeofthe transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms V Whyte

b)

Position/status

Company Secretary

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Descriptionofthe financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

b)

Nature ofthe transaction

Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 9 July 2020, on Ordinary Shares held within an ISA. 

 

c)

Price(s)and volume(s)

Price(s)

Volume(s)

£15.9271

21

 

 

 

d)

Aggregated information

Aggregated volume Price

N/A (single transaction)

 

 

 

 

e)

Date ofthe transaction

2020-07-10

f)

Placeofthe transaction

 

London Stock Exchange (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQXLFFBDLXBBK

Companies

GSK (GSK)
UK 100

Latest directors dealings